TODAY at 12:00 pm ET, Rachel Karchin Johns Hopkins Medicine will discuss the application of #AI in #immunotherapy target discovery during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
TOMORROW at 12:00 pm ET, Rachel Karchin Johns Hopkins Medicine will discuss the application of #AI in #immunotherapy target discovery during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
🚀 Must-Attend Event! 🚀
Join us June 18th at Medicon Village for Lund Immunotalks with experts Johanna Olweus & Inge Marie Svane.
Network during the Fika session, sponsored by Miltenyi Biotec.
Save the date: June 18th, 9-11! 🌟
#LundImmunotalks #ImmunoOncology #Networking
#CIMT2024 is running a great session on machine learning and large language models as tools for #immunooncology Cancer Immunotherapy Mustafa Diken HI-TRON Mainz #machinelearning #ML #LLM #oncology DKFZ Immunology Infection and Cancer
Join us at the #IOTNCapstoneMeeting on May 14 – 15 to learn about scientific accomplishments in #ImmunoOncology across the IOTN Moonshot network. Additional information and registration can be found at events.cancer.gov/dcb/iotncapsto…. #CancerMoonshot
Dr. Lillian Kuo, a Program Director in our division, is kicking off the #IOTNCapstoneMeeting ! events.cancer.gov/dcb/iotncapsto… #CancerMoonshot #ImmunoOncology
DYK that the #IOTNCapstoneMeeting sharing scientific accomplishments in #ImmunoOncology across the IOTN Moonshot will be May 14 & 15? Learn more and register at events.cancer.gov/dcb/iotncapsto…. #CancerMoonshot
Dr. Alan Hutson Roswell Park sharing with us the accomplishments and success from IOTN Moonshot National Cancer Institute #immunoOncology #immunotherapies !! Huge impact on #dataSharing #openScience #teamScience #computational #clinical #translational 🤩
Here’s an application for identifying regions of immune activity and infiltration in breast tumor tissue, defining the highly heterogeneous nature of breast cancer. Samples were stained with a 41-marker #immunooncology panel, acquired with whole slide imaging on Hyperion XTi™.
TOMORROW at 12:00 pm ET, Rachel Karchin Johns Hopkins Medicine will discuss the application of #AI in #immunotherapy target discovery during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
TOMORROW at 12:00 pm ET, Rachel Karchin Johns Hopkins Medicine will discuss the application of #AI in #immunotherapy target discovery during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
Dr. Gerald Linette Penn is discussing engineering the next generation of T cells and T cell receptor (TCR) - T cell therapies for #ImmunoOncology . #IOTNCapstoneMeeting
Some of our experts will be at #ESMOImmuno23 ESMO - Eur. Oncology in Geneva, starting tomorrow! 🥼🩺👩🔬Do not miss them!
Johanna Joyce Solange Peters George Coukos #AndreasHottinger #johnhaanen
CHUV / Centre hospitalier universitaire vaudois Université de Lausanne
#immunooncology #cancer #immunotherapy
Honored to give the Moffitt Cancer Center Moffitt Research #ImmunoOncology #Cancerresearch talk this morning. Excited for all the ongoing and future collaborations #Melanoma #Immunotherapy #Biomarkers #PrecisionMedicine
We are excited to share a major milestone in CRI iAtlas: the addition of 2 datasets with single-cell RNA-seq and analysis modules! #immunoOncology #singlecell #RNAseq
On May 15 at 12:00 pm ET, Rachel Karchin Johns Hopkins Medicine will discuss the application of #AI in #immunotherapy target discovery during an National Cancer Institute & Society for Immunotherapy of Cancer computational #ImmunoOncology webinar: sitcancer.org/education/webi…
Get to know the Immatics story and how we aim to deliver the power of T cells to #cancer patients through our scientific publications. Access a selection of our scientific content here: immatics.com/publications/
#healthcare #immunooncology #biotechnology #scientificpublications
From our #Boston #UserGroupMeeting last fall, here is a sneak peek into the presentation from Kathleen Pfaff, PhD, Principal Scientist Dana-Farber.
She presented on the topic of Quantitative #Multiplex #Assays for Pan-Cancer #ImmunoOncology Studies. bit.ly/42p7RMd